Patents by Inventor NU-CO DEVELOPMENT GMBH

NU-CO DEVELOPMENT GMBH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PEPTIDE ANALOGS FOR TREATING DISEASES AND DISORDERS
    Publication number: 20130183385
    Abstract: A peptide having a sequence selected from SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17 and SEQ ID NO:18. Said peptide used for the treatment of type I diabetes, Type II diabetes, metabolic syndrome, or obesity, or of apetite suppression, or for mitigating insulin resistance, or for reducing an undesirably high fasting serum glucose level, or for reducing an undesirably high peak serum glucose level, or for reducing an undesirably high peak serum insulin level, or for reducing an undesirably large response to a glucose tolerance test.
    Type: Application
    Filed: November 2, 2012
    Publication date: July 18, 2013
    Applicant: NU-CO DEVELOPMENT GMBH
    Inventor: NU-CO DEVELOPMENT GMBH